MedPath

Observational Prospectif Monocentric Registry of Patients Suffering From VIE

Conditions
Venous Thromboembolic Disease
Registration Number
NCT02188056
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Patients with an episode of VTE (DVT and / or PE) have a mortality rate of 16-21% at 1 year after diagnosis. Morbidity associated with VTE is marked by the risk of recurrence, estimated at 30% and estimated at 29% after 8 years of follow post-thrombotic syndrome. For a number of these patients, risk factors have been identified (congenital or acquired thrombophilia, cancer, postpartum, surgery, prolonged immobilization, etc..). In 25-50% of cases, the etiology remains unknown, justifying the need for well-conducted studies to determine other potential risk factors. In addition, the expansion of treatment options with the arrival on the market of new direct oral anticoagulants, allows comparative studies on the effectiveness and frequency of adverse events for each treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • diagnosis of venous thromboembolism established by a validated test (venous Doppler ultrasound of the lower limbs, pulmonary angiography, lung scan ventilation / perfusion),
  • diagnosis of venous thromboembolism made within 15 days,
  • the previous inclusion in the register (outpatient or inpatient)
Exclusion Criteria
  • person doesn't wish to participate in this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of recurrent thromboembolicat 1 year post-diagnosis
bleeding complications incidenceat 1 year post-diagnosis
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service Des Maladies Vasculaires - Hta - Nhc

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath